Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Asthma: Innovair/Innovair Nexthaler is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta₂-agonist) is appropriate: patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta₂-agonist or patients already adequately controlled on both inhaled corticosteroids and long-acting beta₂-agonists.
Note: there are no relevant clinical data on the use of Innovair/Innovair Nexthaler for the treatment of acute asthma attacks.
Innovair/Innovair Nexthaler is indicated for adult patients.
Innovair NEXThaler: COPD: Regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta₂-agonist) is appropriate: patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta₂-agonist or; patients already adequately controlled on both inhaled corticosteroids and long-acting beta₂-agonists.

Innovair/Innovair NEXThaler Indications/Uses

Manufacturer:

Zambon